DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.

Pharmaceutical

DURECT

James E. Brown

Neil Verity

Shesh Verma

John Gibson

Jillian H.

Crystal Susa

Julie Fergus

Brenna Stauffer

Susan Autio

Charlie Claycomb

Alex Haedrich

Samantha Bazzell

Jim Brown

Jian Li

Steve Helmer

Timothy M. Papp

Dorothy Engelking

Norman L. Sussman

Andrew R. Miksztal

Weiqi Lin

David J. Ellis

Judy Joice

Leadership Team

Scientific Research and Development

Director Team

Manufacturing and Production

Operations and Support

Quality Assurance Team

Teams at DURECT